This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Kempharm Denmark A/s. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Mark Read: Innovator in Pharmaceutical Processes
Introduction
Mark Read is an accomplished inventor based in Greenville, SC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of arimoclomol citrate and its intermediates. His innovative work has led to advancements in the methods used to produce high-purity arimoclomol citrate.
Latest Patents
Mark Read holds a patent for "Processes for preparing arimoclomol citrate and intermediates thereof." This patent outlines a process for preparing arimoclomol, arimoclomol citrate, and key intermediates, such as ORZY-01. The disclosure further details methods for achieving high purity arimoclomol citrate and its applications.
Career Highlights
Mark Read is currently employed at Kempharm Denmark A/S, where he continues to develop innovative pharmaceutical processes. His expertise in this area has positioned him as a valuable asset to his company and the industry at large.
Collaborations
Some of his notable coworkers include Elisabeth Vang Carstensen and Zhe Zhang, who contribute to the collaborative environment at Kempharm Denmark A/S.
Conclusion
Mark Read's contributions to pharmaceutical innovations, particularly in the preparation of arimoclomol citrate, highlight his role as a key inventor in the field. His work continues to influence advancements in pharmaceutical processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile